Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Aug 7;27(10):1168–1175. doi: 10.1158/1055-9965.EPI-18-0287

Table 4.

Associations of beta and gamma HPVs species and types with risk of histological type of esophageal cancer

4A. Esophageal Squamous Cell Carcinoma (ESCC)
Beta HPV Species Cases (n=28) Controls (n=83) Adjusted Model* Permutated
Pξ
N % N % OR* 95% CI P
Any Beta HPV 14 50.0 41 49.4 1.05 0.37 – 2.97 0.93 >0.999
Any Beta1 HPV 10 35.7 27 32.5 1.19 0.42 – 3.35 0.75 >0.999
Any Beta2 HPV 11 39.3 33 39.8 0.99 0.36 – 2.72 0.99 >0.999
Any Beta3 HPV 3 10.7 19 22.9 0.35 0.1 – 1.48 0.15 0.792
Specific Beta HPV Types
Beta1 HPV5 5 17.9 10 12.1 1.56 0.44 – 5.53 0.49 >0.999
Beta1 HPV12 3 10.7 9 10.8 1.24 0.26 – 5.79 0.79 >0.999
Beta1 HPV20 3 10.7 8 9.6 1.10 0.25 – 4.81 0.89 >0.999
Beta1 HPV36 4 14.3 6 7.2 1.72 0.36 – 8.14 0.50 >0.999
Clade of Beta1 HPVs 5, 36, 47, & 143 6 21.4 12 14.5 1.31 0.39 – 4.39 0.66 >0.999
Beta2 HPV23 2 7.1 6 7.2 1.31 0.20 – 8.38 0.78 >0.999
Beta2 HPV38 4 14.3 16 19.3 0.62 0.18 – 2.11 0.45 >0.999
Gamma HPV Species
Any Gamma HPV 12 42.9 26 31.3 1.31 0.51 – 3.31 0.57 >0.999
Any Gamma7 HPV 3 10.7 6 7.2 0.81 0.15 – 4.48 0.81 >0.999
Any Gamma8 HPV 3 10.7 9 10.8 0.61 0.12 – 3.11 0.55 >0.999
Any Gamma10 HPV 4 14.3 8 9.6 1.46 0.37 – 5.82 0.59 >0.999
Any Gamma15 HPV 3 10.7 8 9.6 1.22 0.29 – 5.14 0.79 >0.999
4B. Esophageal Adenocarcinoma
Beta HPV Species Cases (n=80) Controls (n=239) Adjusted Model* Permutated
Pξ
N % N % OR* 95% CI p
Any Beta HPV 56 70.0 134 56.1 1.84 1.05 – 3.23 0.04 0.199
Any Beta1 HPV 41 51.3 94 39.3 1.74 1.00 – 3.04 0.05 0.296
Any Beta2 HPV 42 52.5 105 43.9 1.34 0.80 – 2.25 0.27 >0.999
Any Beta3 HPV 18 22.5 34 14.2 1.86 0.95 – 3.63 0.07 0.363
Specific Beta HPV Types
Beta1 HPV5 14 17.5 27 11.3 1.78 0.85 – 3.72 0.13 0.605
Beta1 HPV12 6 7.5 16 6.7 1.11 0.42 – 2.93 0.83 >0.999
Beta1 HPV20 14 17.5 31 13.0 1.42 0.70 – 2.91 0.33 >0.999
Beta1 HPV36 10 12.5 23 9.6 1.13 0.50 – 2.55 0.77 >0.999
Clade of Beta1 HPVs 5, 36, 47, & 143 17 21.3 39 16.3 1.36 0.71 – 2.58 0.35 >0.999
Beta1 HPV105 11 13.8 20 8.4 1.62 0.72 – 3.63 0.24 >0.999
Beta1 HPV124 7 8.8 20 8.4 1.06 0.42 – 2.67 0.90 >0.999
Beta2 HPV23 9 11.3 17 7.1 1.67 0.70 – 3.97 0.24 >0.999
Beta2 HPV37 8 10.0 21 8.8 1.21 0.49 – 2.97 0.68 >0.999
Beta2 HPV38 15 18.8 34 14.2 1.48 0.75 – 2.92 0.26 >0.999
Beta2 HPV107 10 12.5 19 8.0 1.69 0.72 – 3.98 0.23 >0.999
Gamma HPV Species
Any Gamma HPV 32 40.0 77 32.2 1.53 0.86 – 2.70 0.15 0.668
Any Gamma7 HPV 13 16.3 34 14.2 1.12 0.54 – 2.34 0.76 >0.999
Any Gamma8 HPV 4 5.0 21 8.8 0.43 0.14 – 1.36 0.15 >0.999
Any Gamma10 HPV 7 8.8 17 7.1 1.38 0.52 – 3.66 0.52 >0.999
Any Gamma12 HPV 7 8.8 13 5.4 1.92 0.72 – 5.14 0.19 >0.999
Any Gamma15 HPV 8 10.0 14 5.9 1.93 0.69 – 5.42 0.21 >0.999

Beta and gamma HPV species and types presented have a prevalence of 5% or higher either in cases or controls

*

OR and 95% CI were estimated from conditional logistic regression models adjusted for smoking, alcohol consumption, and study cohort

ξ

Permutated P-values were calculated to account for multiple comparisons (see methods)